Business development and Innovation

The Business development and Innovation Area, has the purpose of connecting academia and industry in order to promote innovative ideas to the market and therefore to society, by supoporting professionals along the process.

The Area is responsible for evaluating the innovation projects created at IDIBELL in order to encourage the establishment of research-industry translational collaborations. It is composed by two units: Business development and Innovation.

The Innovation Unit is in charge of evaluating and valuing innovative research projects and supporting the generation of project development strategies and their protection through industrial/intellectual property, as well as looking for industrial partners for financing and transfering to market.

The Business Development Unit is in charge of seeking alliances, proposing strategies for the profitability of research projects and raising new institutional business opportunities, as well as monitoring all agreements already signed with the industry.

Units

Tasks

Evaluation of innovation and management of the IDIBELL project portfolio
Advice on protection of technology
Design of commercial and development plans
Performance of training and informative activities
Creation of public and private funding strategies
Negotiations, drafting of agreements and legal advice
Search for strategic partners, creation of innovative consortia
Assistance in the creation of spin-off companies
Search for private investors
Monitoring of agreements signed with the industry
Creation of new business models

UNE 166002 certification

The IDIBELL business development and innovation area is accredited with the UNE 166002:2021 certification. This seal certifies that IDIBELL is capable of generating and managing innovation projects, systematizing R+D+I activities and ensuring that they are carried out effectively and efficiently, specifically in the development and innovation of drugs, biomarkers, medical devices and software clinical field within the fields of oncology, neuroscience, translational and regenerative medicine.

It was in 2021, when IDIBELL began the process of implementing the management system under the UNE 166002:2014 Standard, being accredited for the first time and successfully passing the annual audits carried out until reaching the current certificate in accordance with the UNE 166002:2021 standard.

EATRIS accreditation

The Business Development and Innovation Area is accredited as an expert center in innovation, business development and regulation by EATRIS. This accreditation opens IDIBELL the possibility of offering services and strategic collaborations to academic and research centers throughout Europe.

EATRIS is the European network of research infrastructures in translational medicine whose objective is to establish a specialized infrastructure in biomedicine to optimize the access of basic research results to clinical applications. Through a network of experts, EATRIS offers decentralized expert services in key areas of medical product development, from the validation process of therapeutic targets to the first phases of clinical trials.